TAFAZZIN and Barth syndrome: Mutations in tafazzin cause Barth syndrome (BTHS), a disease associated with L4-cardiolipin deficiency, resulting in variable clinical findings including cardiac and skeletal myopathies as well as immunological deficits and changes in cognition, taste, and sensory perception, among other symptoms [13].